TITLE

Sensor monitors tumors, radiation doses

PUB. DATE
August 2006
SOURCE
Mobile Radio Technology;Aug2006, Vol. 24 Issue 8, p69
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article introduces a wireless, implantable radiation sensor one of the dose verification system developed by Sicel Technologies Inc. which was recently approved by the U.S. Food and Drug Administration for mass market and for use in breast cancer patients. It is used to monitor patients currently undergoing treatment for prostate cancer.
ACCESSION #
21923614

 

Related Articles

  • Sicel wins reimbursement code for 1st radiation sensor. Yoffee, Lynn // Medical Device Daily;5/22/2008, Vol. 12 Issue 99, p1 

    The article announces that Sicel Technologies of Raleigh, North Carolina, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Dose Verification System (DVS). It is a wireless implantable radiation sensor and reader that helps radiation oncologists determine if the radiation...

  • Sicel wins reimbursement code for 1st radiation sensor. Yoffee, Lynn // Diagnostics & Imaging Week;5/29/2008, Vol. 11 Issue 22, p1 

    The article reports on the success of Sicel Technologies to get reimbursement code for its Dose Verification System (DVS), a wireless implantable radiation sensor and reader designed to help radiation oncologists determine if the radiation they are administering has hit its target. According to...

  • Accuray gets FDA nod to offer lung treatment via CyberKnife. FORD, OMAR // Medical Device Daily;12/16/2010, Vol. 14 Issue 243, p1 

    The article reports that Accuray has been granted with U.S. Food and Drug Administration (FDA) clearance in December 2010 for the marketing of Lung Optimized Treatment, a new component of the CyberKnife VSI System. Correspondingly, the 501(k) clearance allows the company to offer doctors with...

  • Elekta shows off 'Agility' with FDA clearance. Ford, Omar // Medical Device Daily;6/25/2012, Vol. 16 Issue 120, p1 

    The article reports on the clearance granted by the U.S. Food and Drug Administration (FDA) to Agility multi-leaf collimator (MLC), a medical device used to shape beams of therapeutic radiation for cancer treatment, from Elekta. The Agility device offers health benefits to patients. A study...

  • Panel recommends RCTs for prostate cancer treatments. McCARTY, MARK // Medical Device Daily;12/15/2009, Vol. 13 Issue 240, p1 

    The article focuses on a statement by a panel from the U.S. Food and Drug Administration (FDA) that randomized clinical trials (RCTs) are necessary for devices used in the treatment of prostate cancer. This was despite physicians' claims of difficulty in finding enrollees to the RCTs. According...

  • OBSERVATIONS. Formanek Jr., Raymond // FDA Consumer;May/Jun2006, Vol. 40 Issue 3, p2 

    The article presents an introduction to a series of articles about the efforts by the U.S. Food and Drug Administration to improve cancer treatments and ensure the safety of medical devices.

  • New Products & Services.  // Urology Times;8/15/2006, Vol. 34 Issue 10, p38 

    The article introduces several newly develop biological apparatus. They include the PICSI sperm selection device developed by Biocoat Inc. that facilitates assisted reproduction which recently acquired Food and Drug Administration approval, a compact x-ray/computed radiography unit CR-ITX 560...

  • Biosensors Improve Diagnostic Abilities for Heart, Orthopedic Care. Mitka, Mike // JAMA: Journal of the American Medical Association;12/13/2006, Vol. 296 Issue 22, p2667 

    This article discusses the use of biosensors for improved diagnostics of heart and orthopedic conditions. The EndoSure Sensor by CardioMEMS has been approved by the U.S. Food and Drug Administration for monitoring endografts used to treat abdominal aortic aneurysms. The experimental biosensors...

  • Anaxsys Files 510(k) for respiR8(tm) Continuous Respiratory Rate Counter.  // Biomedical Market Newsletter;7/26/2012, Vol. 21, p1 

    The article informs that Anaxsys Ltd. has filed a 510(k) Premarket Notification with the U.S. Food and Drug Administration (FDA) for regulatory clearance for respiR8 continuous respiratory rate counter. It mentions that respiR8 has also received a CE Mark and is available in hospitals in the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics